Docetaxel +/- Suramin in 2nd Line Advanced Non-Small Cell Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01671332
Recruitment Status : Active, not recruiting
First Posted : August 23, 2012
Last Update Posted : September 2, 2016
Medical College of Wisconsin
Optimum Therapeutics, LLC
Ohio State University
Information provided by (Responsible Party):
University of Wisconsin, Madison

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : June 2015
  Estimated Study Completion Date : December 2016
  Certification/Extension First Submitted : June 29, 2016